Genprex, Inc. Prices $17500000 Common Stock Offering Priced At-The-Market and Without Warrants – Business Wire
Genprex, Inc. Prices $17500000 Common Stock Offering Priced At-The-Market and Without Warrants Business Wire
Genprex, Inc. Prices $17500000 Common Stock Offering Priced At-The-Market and Without Warrants Business Wire
AVEO Announces Effectiveness of 1-for-10 Reverse Stock Split Business Wire
AVEO Announces Effectiveness of 1-for-10 Reverse Stock Split – Business Wire Read More »
Form S-3ASR American Airlines Group StreetInsider.com
Form S-3ASR American Airlines Group – StreetInsider.com Read More »
Form SC 13D Landcadia Holdings II, Filed by: FERTITTA TILMAN J StreetInsider.com
Form SC 13D Landcadia Holdings II, Filed by: FERTITTA TILMAN J – StreetInsider.com Read More »
PAVmed Adds EsoCure™ Esophageal Ablation Device with Patented Caldus™ Technology to Commercial Product Pipeline StreetInsider.com
Virgin Galactic Holdings (SPCE) Gains But 31M Share Issuance in Focus StreetInsider.com
Aytu BioScience Completes Acquisition of Innovus Pharmaceuticals Yahoo Finance
Aytu BioScience Completes Acquisition of Innovus Pharmaceuticals – Yahoo Finance Read More »
HealthLynked Corp Steps Up March Toward Profitability; Agrees To Acquire Cura Health Management and ACO Health Partners, LLC Yahoo Finance
Zosano Pharma Corporation (ZSAN) see a hike on Friday, Is that a price correction following the negative reaction over Public Offering? News Welcome
Kezar Life Sciences, Inc. (KZR) Everything Investors Need To Know The News Heater
Kezar Life Sciences, Inc. (KZR) Everything Investors Need To Know – The News Heater Read More »